EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Imatinib decreases germ cell survival and germline stem cell proliferation in rodent testis ex vivo and in vitro

Anna Eggert iD, Sini Laasanen, Mirja Nurmio, Aida Wahlgren, Kirsi Jahnukainen, Kim Eerola, Miisael Nieminen, Opeyemi Olotu, Noora Kotaja, Juho-Antti Mäkelä iD, Jorma Toppari iD

Andrology · 2025

DOI: 10.1111/andr.13777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Andrology, 2025. Verfasst von Anna Eggert und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland. Hauptthemen laut MEDLINE: Imatinib Mesylate, Tyrosine Kinase Inhibitors, Seminiferous Tubules, Spermatozoa. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Imatinib and dasatinib are tyrosine kinase inhibitors (TKIs) increasingly used to treat several diseases in both children and adults at fertile age. We have previously shown that imatinib has adverse effects on developing testis, and imatinib‐treated male patients have been reported to have reduced sperm counts. However, the cellular level effects of imatinib and dasatinib on adult male germ cells and germline stem cells (mGSCs) have not been thoroughly investigated.

Objectives

To analyze whether imatinib or dasatinib exposure ex vivo and in vitro is harmful to adult male rodent germ cells and mGSCs. Materials and methods Seminiferous tubule segments of adult male mouse or rat were cultured in the presence or the absence of imatinib or dasatinib. Stage‐specific effects were monitored by 3 H‐thymidine incorporation assay (DNA synthesis), immunohistochemistry (cleaved Caspase‐3; apoptosis), immunofluorescence (KI67, GFRα1, STRA8, c‐KIT, LIN28A; proliferation and spermatogonial differentiation) and flow cytometry (Hoechst). Mouse mGSCs were exposed to imatinib and dasatinib to study proliferation, apoptosis, and differentiation.

Results

Imatinib decreased stage‐specific DNA synthesis, and induced apoptosis in cultured rat seminiferous tubule segments. Imatinib also had an adverse effect on mGSC proliferation both in vitro and ex vivo, but did not induce cell death in cultured mGSCs. Imatinib did not impinge on induction of spermatogonial differentiation but suppressed c‐KIT expression in nascent differentiating spermatogonia, providing a plausible mechanism for its pro‐apoptotic function in spermatogenic cells. Clinically relevant doses of dasatinib did not induce apoptosis in seminiferous tubules but decreased mGSC colony growth in vitro.

Conclusions

Imatinib exposure ex vivo and in vitro impinges on male rodent germ cell proliferation and survival. The plausible mechanism in spermatogenic cells is the inhibition of SCF/c‐KIT signaling, and reduced expression of c‐KIT. Dasatinib did not show significant adverse effects with clinical doses ex vivo but inhibited mGSC colony growth in vitro.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Imatinib MesylateTyrosine Kinase InhibitorsSeminiferous TubulesSpermatozoaAdult Germline Stem CellsCell ProliferationMaleAnimalsMiceRatsDasatinibCell SurvivalApoptosisCell DifferentiationProto-Oncogene Proteins c-kitStem Cell FactorSignal TransductionPrimary Cell Culture

Stichwörter der Autor:innen

dasatinibimatinibmale fertilitymale germline stem cellsspermatogenesistestis

Substanzen

Imatinib MesylateTyrosine Kinase InhibitorsDasatinibProto-Oncogene Proteins c-kitStem Cell Factor

Autor:innen und Institutionen

  • Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.
  • Tyks Acute, Turku University Hospital, Turku, Finland.
  • Department of Women's and Children's Health, Karolinska Institutet and University Hospital, Solna, Sweden.
  • Division of Hematology-Oncology and Stem Cell Transplantation, New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Department of Genomics, Turku University Hospital Laboratories, Turku, Finland.
  • Department of Pediatrics, Turku University Hospital, Turku, Finland.

ORCID-Profile: Anna Eggert, Juho-Antti Mäkelä, Jorma Toppari

Zitieren

APA

Eggert, A., Laasanen, S., Nurmio, M., Wahlgren, A., Jahnukainen, K., Eerola, K., Nieminen, M., Olotu, O., Kotaja, N., Mäkelä, J. A., & Toppari, J. (2025). Imatinib decreases germ cell survival and germline stem cell proliferation in rodent testis ex vivo and in vitro. Andrology. https://doi.org/10.1111/andr.13777

Vancouver

Eggert A, Laasanen S, Nurmio M, Wahlgren A, Jahnukainen K, Eerola K, et al. Imatinib decreases germ cell survival and germline stem cell proliferation in rodent testis ex vivo and in vitro. Andrology. 2025. doi:10.1111/andr.13777

BibTeX
@article{Eggert2025,
  author = {Eggert, Anna and Laasanen, Sini and Nurmio, Mirja and Wahlgren, Aida and Jahnukainen, Kirsi and Eerola, Kim and Nieminen, Miisael and Olotu, Opeyemi and Kotaja, Noora and Mäkelä, Juho-Antti and Toppari, Jorma},
  title = {Imatinib decreases germ cell survival and germline stem cell proliferation in rodent testis ex vivo and in vitro},
  journal = {Andrology},
  year = {2025},
  doi = {10.1111/andr.13777}
}
Kostenlos starten →